Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 19, 2020NeurosurgeryOpen Access

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events

View Full Paper
Ask AI
Bookmark
Share

Authors

KZKang ZengASArjun SahgalCTChia‐Lin Tseng

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zeng et al. (2020) studied this question.

synapsesocial.com/papers/6aa8de2bb17909331cd917dchttps://doi.org/10.1093/neuros/nyaa583
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview2019 · 112 citations
  2. 2Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer2019 · 1,649 citations
  3. 3Radiosurgery for Spinal Metastases2007 · 745 citations